BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27549307)

  • 1. Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD.
    Carapito R; Jung N; Kwemou M; Untrau M; Michel S; Pichot A; Giacometti G; Macquin C; Ilias W; Morlon A; Kotova I; Apostolova P; Schmitt-Graeff A; Cesbron A; Gagne K; Oudshoorn M; van der Holt B; Labalette M; Spierings E; Picard C; Loiseau P; Tamouza R; Toubert A; Parissiadis A; Dubois V; Lafarge X; Maumy-Bertrand M; Bertrand F; Vago L; Ciceri F; Paillard C; Querol S; Sierra J; Fleischhauer K; Nagler A; Labopin M; Inoko H; von dem Borne PA; Kuball J; Ota M; Katsuyama Y; Michallet M; Lioure B; Peffault de Latour R; Blaise D; Cornelissen JJ; Yakoub-Agha I; Claas F; Moreau P; Milpied N; Charron D; Mohty M; Zeiser R; Socié G; Bahram S
    Blood; 2016 Oct; 128(15):1979-1986. PubMed ID: 27549307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of polymorphic MHC microsatellites with GVHD, survival, and leukemia relapse in unrelated hematopoietic stem cell transplant donor/recipient pairs matched at five HLA loci.
    Li S; Kawata H; Katsuyama Y; Ota M; Morishima Y; Mano S; Kulski JK; Naruse T; Inoko H
    Tissue Antigens; 2004 Apr; 63(4):362-8. PubMed ID: 15009808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome: A Center for International Blood and Marrow Transplant Research Study.
    Askar M; Sobecks R; Wang T; Haagenson M; Majhail N; Madbouly A; Thomas D; Zhang A; Fleischhauer K; Hsu K; Verneris M; Lee SJ; Spellman SR; Fernández-Viña M
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):436-444. PubMed ID: 27987385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matching for the MICA-129 polymorphism is beneficial in unrelated hematopoietic stem cell transplantation.
    Fuerst D; Neuchel C; Niederwieser D; Bunjes D; Gramatzki M; Wagner E; Wulf G; Glass B; Pfreundschuh M; Einsele H; Arnold R; Stuhler G; Schaefer-Eckart K; Freitag S; Casper J; Kaufmann M; Wattad M; Hertenstein B; Klein S; Ringhoffer M; Mytilineos D; Tsamadou C; Mueller C; Schrezenmeier H; Mytilineos J
    Blood; 2016 Dec; 128(26):3169-3176. PubMed ID: 27811019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of major histocompatibility complex haplotype matching by C4 and MICA genotyping on acute graft versus host disease in unrelated hematopoietic stem cell transplantation.
    Park Y; Cheong JW; Park MH; Kim MS; Kim JS; Kim HS
    Hum Immunol; 2016 Feb; 77(2):176-83. PubMed ID: 26602146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status.
    Carapito R; Aouadi I; Pichot A; Spinnhirny P; Morlon A; Kotova I; Macquin C; Rolli V; Cesbron A; Gagne K; Oudshoorn M; van der Holt B; Labalette M; Spierings E; Picard C; Loiseau P; Tamouza R; Toubert A; Parissiadis A; Dubois V; Paillard C; Maumy-Bertrand M; Bertrand F; von dem Borne PA; Kuball JHE; Michallet M; Lioure B; Peffault de Latour R; Blaise D; Cornelissen JJ; Yakoub-Agha I; Claas F; Moreau P; Charron D; Mohty M; Morishima Y; Socié G; Bahram S
    Bone Marrow Transplant; 2020 Jul; 55(7):1367-1378. PubMed ID: 32286503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation.
    Askar M; Sun Y; Rybicki L; Zhang A; Thomas D; Kalaycio M; Pohlman B; Dean R; Duong H; Hanna R; Maciejewski J; Majhail NS; Bolwell B; Sobecks R
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1835-40. PubMed ID: 25064744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.
    Martin PJ; Levine DM; Storer BE; Warren EH; Zheng X; Nelson SC; Smith AG; Mortensen BK; Hansen JA
    Blood; 2017 Feb; 129(6):791-798. PubMed ID: 27872059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study.
    Petersdorf EW; Carrington M; O'hUigin C; Bengtsson M; De Santis D; Dubois V; Gooley T; Horowitz M; Hsu K; Madrigal JA; Maiers MJ; Malkki M; McKallor C; Morishima Y; Oudshoorn M; Spellman SR; Villard J; Stevenson P;
    Lancet Haematol; 2020 Jan; 7(1):e50-e60. PubMed ID: 31669248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.
    Parmar S; Del Lima M; Zou Y; Patah PA; Liu P; Cano P; Rondon G; Pesoa S; de Padua Silva L; Qazilbash MH; Hosing C; Popat U; Kebriaei P; Shpall EJ; Giralt S; Champlin RE; Stastny P; Fernandez-Vina M
    Blood; 2009 Oct; 114(14):2884-7. PubMed ID: 19654407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.
    Pidala J; Wang T; Haagenson M; Spellman SR; Askar M; Battiwalla M; Baxter-Lowe LA; Bitan M; Fernandez-Viña M; Gandhi M; Jakubowski AA; Maiers M; Marino SR; Marsh SG; Oudshoorn M; Palmer J; Prasad VK; Reddy V; Ringden O; Saber W; Santarone S; Schultz KR; Setterholm M; Trachtenberg E; Turner EV; Woolfrey AE; Lee SJ; Anasetti C
    Blood; 2013 Nov; 122(22):3651-8. PubMed ID: 23982174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC haplotype matching for unrelated hematopoietic cell transplantation.
    Petersdorf EW; Malkki M; Gooley TA; Martin PJ; Guo Z
    PLoS Med; 2007 Jan; 4(1):e8. PubMed ID: 17378697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Case for High Resolution Extended 6-Loci HLA Typing for Identifying Related Donors in the Indian Subcontinent.
    Agarwal RK; Kumari A; Sedai A; Parmar L; Dhanya R; Faulkner L
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1592-1596. PubMed ID: 28603069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
    Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.
    Morishima Y; Kashiwase K; Matsuo K; Azuma F; Morishima S; Onizuka M; Yabe T; Murata M; Doki N; Eto T; Mori T; Miyamura K; Sao H; Ichinohe T; Saji H; Kato S; Atsuta Y; Kawa K; Kodera Y; Sasazuki T;
    Blood; 2015 Feb; 125(7):1189-97. PubMed ID: 25519752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research.
    Lazaryan A; Wang T; Spellman SR; Wang HL; Pidala J; Nishihori T; Askar M; Olsson R; Oudshoorn M; Abdel-Azim H; Yong A; Gandhi M; Dandoy C; Savani B; Hale G; Page K; Bitan M; Reshef R; Drobyski W; Marsh SG; Schultz K; Müller CR; Fernandez-Viña MA; Verneris MR; Horowitz MM; Arora M; Weisdorf DJ; Lee SJ
    Haematologica; 2016 Oct; 101(10):1267-1274. PubMed ID: 27247320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.
    Sasazuki T; Juji T; Morishima Y; Kinukawa N; Kashiwabara H; Inoko H; Yoshida T; Kimura A; Akaza T; Kamikawaji N; Kodera Y; Takaku F
    N Engl J Med; 1998 Oct; 339(17):1177-85. PubMed ID: 9780337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
    Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
    Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of HLA mismatch on acute graft-versus-host disease.
    Kanda J
    Int J Hematol; 2013 Sep; 98(3):300-8. PubMed ID: 23893313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.